Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer

BACKGROUND: The outcome of patients with metastatic colorectal carcinoma (mCRC) following first line therapy is poor, with median survival of less than one year. The purpose of this study was to identify candidate therapeutically targetable somatic events in mCRC patient samples by whole genome sequ...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shanmugam, Vijayalakshmi, Ramanathan, Ramesh K, Lavender, Nicole A, Sinari, Shripad, Chadha, Manpreet, Liang, Winnie S, Kurdoglu, Ahmet, Izatt, Tyler, Christoforides, Alexis, Benson, Hollie, Phillips, Lori, Baker, Angela, Murray, Christopher, Hostetter, Galen, Von Hoff, Daniel D, Craig, David W, Carpten, John D
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074842/
https://ncbi.nlm.nih.gov/pubmed/24943349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-7-36
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים